Business Description
Biovica International AB
ISIN : SE0008613731
Share Class Description:
FRA:9II: Class BCompare
Compare
Traded in other countries / regions
BIOVIC B.Sweden9II.Germany IPO Date
2020-12-14Description
Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.81 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.07 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.54 | |||||
Beneish M-Score | -1.93 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13 | |||||
3-Year EBITDA Growth Rate | -41.6 | |||||
3-Year EPS without NRI Growth Rate | -35.9 | |||||
3-Year FCF Growth Rate | -29.6 | |||||
3-Year Book Growth Rate | -2.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.31 | |||||
9-Day RSI | 45.98 | |||||
14-Day RSI | 49.27 | |||||
6-1 Month Momentum % | -46.44 | |||||
12-1 Month Momentum % | -79.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.27 | |||||
Quick Ratio | 7.1 | |||||
Cash Ratio | 6.77 | |||||
Days Sales Outstanding | 71.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.3 | |||||
Shareholder Yield % | 1.31 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 113.43 | |||||
Operating Margin % | -1929 | |||||
Net Margin % | -1938.68 | |||||
FCF Margin % | -1890.91 | |||||
ROE % | -96.3 | |||||
ROA % | -79.48 | |||||
ROIC % | -195.74 | |||||
ROC (Joel Greenblatt) % | -1145.1 | |||||
ROCE % | -87.77 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 19.66 | |||||
PB Ratio | 1.62 | |||||
Price-to-Tangible-Book | 1.68 | |||||
EV-to-EBIT | -0.87 | |||||
EV-to-Forward-EBIT | -2.04 | |||||
EV-to-EBITDA | -0.95 | |||||
EV-to-Forward-EBITDA | -2.63 | |||||
EV-to-Revenue | 16.56 | |||||
EV-to-Forward-Revenue | 2.24 | |||||
EV-to-FCF | -1.03 | |||||
Price-to-Net-Current-Asset-Value | 1.87 | |||||
Price-to-Net-Cash | 2.1 | |||||
Earnings Yield (Greenblatt) % | -114.54 | |||||
FCF Yield % | -59.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biovica International AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.55 | ||
EPS (TTM) (€) | -0.224 | ||
Beta | 1.43 | ||
Volatility % | 109.19 | ||
14-Day RSI | 49.27 | ||
14-Day ATR (€) | 0.016413 | ||
20-Day SMA (€) | 0.17599 | ||
12-1 Month Momentum % | -79.04 | ||
52-Week Range (€) | 0.1012 - 0.842 | ||
Shares Outstanding (Mil) | 84.06 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biovica International AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biovica International AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biovica International AB Frequently Asked Questions
What is Biovica International AB(FRA:9II)'s stock price today?
The current price of FRA:9II is €0.17. The 52 week high of FRA:9II is €0.84 and 52 week low is €0.10.
When is next earnings date of Biovica International AB(FRA:9II)?
The next earnings date of Biovica International AB(FRA:9II) is 2024-09-06 Est..
Does Biovica International AB(FRA:9II) pay dividends? If so, how much?
Biovica International AB(FRA:9II) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |